The news agency reports that Truman, who focuses on advising pharmaceutical and biotech companies, has worked on a number of high-profile transactions recently, including Hospira's $17bn sale to Pfizer and Abbott Laboratories' $5.3bn sale of a part of its generics business to Mylan NV. He also was a member of Morgan Stanley's shareholder activist defense group.
In the meantime, Reuters also reports that Credit Suisse has changed the roles of two of its bankers on the firm's financial institutions syndicate desk following a departure from the team earlier this year, according to one person with knowledge of the information.
Dhiren Shah, who previously worked on financial institutions funding and sovereign, supranationals and agencies, will now look after emerging markets and corporates. He will continue to focus on covered bond trades. David Anthony will work alongside Shah.